Argentum Medical, LLC, a Geneva, IL-based manufactures and sells innovative wound care products, received a growth investment from Shore Capital Partners.
The amount of the deal, which is also related to certain assets of Cura Surgical, Inc., was not disclosed.
Shore’s investment will enable the company to focus on expanding sales and marketing efforts with U.S. hospitals, burn and wound care centers, as well as with international customers and to pursue acquisitions to broaden its advanced wound care and infection prevention portfolio.
Founded in 2001 and led by Raul Brizuela, CEO, Argentum Medical manufactures and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® brand, its proprietary range of silver-based antimicrobial products.
The core platform technology in Silverlon is a silver-plated nylon matrix that provides antimicrobial properties of silver ions in the dressing without staining the skin and without increasing bioburden. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure wound therapy.